Learn more about BRCAvantage™ and BRCAvantage Plus™
Doctor talking to patient about testing for BRCA1 and BRCA2 genetics.

Comprehensive hereditary breast cancer risk testing menu, including BRCA1 and BRCA2, and expanded testing for significant breast cancer susceptibility genes.

It's Best to Test
It's Best to Test logo

Are your patients at risk of chlamydia and gonorrhea infection? Find out why It's Best to Test.

A significant innovation in cervical cancer screening
The performance of the HPV test you choose matters

See the Sensitivity and Specificity sections at Aptimaforher.com to learn more about Aptima® HPV mRNA performance.

Zika Virus

Zika Virus Infection

We offer testing for emerging infections, including Zika virus. Learn more about testing and the Zika virus.

Male employee at podium

“Advances in Cervical Cancer Screening and A New Approach to the Pelvic Mass,”

Darren Wheeler, MD discusses recent advances regarding HPV and Pap co-testing, emerging technologies and clinical approaches.

Jon Nakamoto, MD, PhD, is giving a presentation

Female testosterone testing

Jon Nakamoto, MD, PhD compares and contrasts current testosterone assays and discusses appropriate testosterone testing for female patients. Video includes clinical case studies on a variety of conditions.

Physician working at computer

Test Interpretation Guides

See our guides for details on test selection, utilization and interpretation. All information is based on peer-reviewed publications and practice guidelines.